Role of tuberculosis laboratories in Saudi Arabia. A call to implement standardized procedures

Saudi Medical Journal

Volumn 25, Issue 11, 2004, Pages 1545-1548

  Al Hajoj, Sahal A ^a   Alrabiah, Fahad A ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HUMAN; LABORATORY TEST; RADIOGRAPHY; SAFETY; SAUDI ARABIA; STAFF TRAINING; STANDARDIZATION; TUBERCULOSIS; TUBERCULOSIS CONTROL;

BACTERIOLOGICAL TECHNIQUES; DNA FINGERPRINTING; HUMANS; LABORATORIES, HOSPITAL; LABORATORY INFECTION; LABORATORY TECHNIQUES AND PROCEDURES; QUALITY CONTROL; SAUDI ARABIA; TUBERCULOSIS, PULMONARY;

EID: 10644272641     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Northrup JM, Miller AC, Nardell E, Sharnprapai S, Etkind S, Driscoll J et al. Estimated costs of false laboratory diagnoses of tuberculosis in three patients. Emerg Infect Dis 2002; 8: 1264-1270.
2. Jasmer RM, Ponce de Leon A, Hopewell PC, Alarcon RG, Moss AR, Paz EA et al. Tuberculosis in Mexican-born persons in San Francisco: reactivation, acquired infection and transmission. Ja Int J Tuberc Lung Dis 1997; 1: 536-541.
3. Carroll NM, Richardson M, Engelke E, de Kock M, Lombard C, van Helden PD. Reduction of the rate of false-positive cultures of Mycobacterium tuberculosis in a laboratory with a high culture positivity rate. Clin Chem Lab Med 2002; 40: 888-892.
4. Ritacco V, Lopez B, Paul R, Reniero A, Di Lonardo M, Casimir L et al. False-positive cultures due to cross contamination in tuberculosis laboratories. Rev Argent Microbiol 2002; 34: 163-166.
5. Poynten M, Andresen DN, Gottlieb T. Laboratory cross-contamination of Mycobacterium tuberculosis: an investigation and analysis of causes and consequences. Intern Med J 2002; 32: 512-519.
6. Ruddy M, McHugh TD, Dale JW, Banerjee D, Maguire H, Wilson P et al. Estimation of the rate of unrecognized cross-contamination with mycobacterium tuberculosis in London microbiology laboratories. J Clin Microbiol 2002; 40: 4100-4104.
7. Woods GL, Witebsky FG. Current status of mycobacterial testing in clinical laboratories. Results of a questionnaire completed by participants in the College of American Pathologists Mycobacteriology E survey. Arch Pathol Lab Med 1993; 117: 876-884.
8. Heymann SJ, Brewer TF, Ettling M. Effectiveness and cost of rapid and conventional laboratory methods for Mycobacterium tuberculosis screening. Public Health Rep 1997; 112: 513-523.
9. Tokars JI, Rudnick JR, Kroc K, Manangan L, Pugliese G, Huebner RE et al. U.S. hospital mycobacteriology laboratories: status and comparison with state public health department laboratories. J Clin Microbiol 1996; 34: 680-685.
10. Bird BR, Denniston MM, Huebner RE, Good RC. Changing practices in mycobacteriology: a follow-up survey of state and territorial public health laboratories. J Clin Microbiol 1996; 34: 554-559.
11. Huebner RE, Good RC, Tokars JI. Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol 1993; 31: 771-775.
12. Roring S, Hughes MS, Beck LA, Skuce RA, Neill SD. Rapid diagnosis and strain differentiation of Mycobacterium bovis in radiometric culture by spoligotyping. Vet Microbiol 1998; 61: 71-80.
13. Heifers LB. Rapid automated methods (BACTEC System) in clinical mycobacteriology. Semin Respir Infect 1986; 1: 242-249.
14. Parsons LM, Brosch R, Cole ST, Somoskovi A, Loder A, Bretzel G et al. Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis. J Clin Microbiol 2002; 40: 2339-2345
15. Abe C. Standardization of laboratory tests for tuberculosis and their proficiency testing. Kekkaku 2003; 78: 541-551.
16. Van Doorn HR, Kuijper EJ, van der Ende A, Welten AG, van Soolingen D, de Haas PE et al. The susceptibility of Mycobacterium tuberculosis to isoniazid and the Arg-->Leu mutation at codon 463 of katG are not associated. J Clin Microbiol 2001; 39: 1591-1594.
17. Kruuner A, Jureen P, Levina K, Ghebremichael S, Hoffner S. Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2003; 47: 2971-2933.
18. Bartu V, Hricikova I, Kopecka E, Vasakova M. Results of treatment of multiresistant tuberculosis. Cas Lek Cesk 2003; 142: 226-228.
19. Banaiee N, Bobadilla-del-Valle M, Riska PF, Bardarov S Jr, Small PM, Ponce-de-Leon A et al. Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages. J Med Microbiol 2003; 52 (Pt 7): 557-561.
20. Aono A, Hirano K, Hamasaki S, Abe C. Evaluation of BACTEC MGIT 960 PZA medium for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide (PZA): compared with the results of pyrazinamidase assay and Kyokuto PZA test. Diagn Microbiol Infect Dis 2002; 44: 347-352.
21. de Ramos M, Soini H, Roscanni GC, Jaques M, Villares MC, Musser JM. Extensive cross-contamination of specimens with Mycobacterium tuberculosis in a reference laboratory. J Clin Microbiol 1999; 37: 916-919.
22. Segal-Maurer S, Kreiswirth BN, Burns JM, Lavie S, Lim M, Urban C et al. Mycobacterium tuberculosis specimen contamination revisited: the role of laboratory environmental control in a pseudo-outbreak. Infect Control Hosp Epidemiol 1998; 19: 101-105.
23. Bhattacharya M, Dietrich S, Mosher L, Siddiqui F, Reisberg BE, Paul WS et al. Cross-contamination of specimens with Mycobacterium tuberculosis: clinical significance, causes, and prevention. Am J Clin Pathol 1998; 109: 324-330.
24. Spitzer ED. Tracking Mycobacterium tuberculosis in the laboratory. Am J Clin Pathol 1998; 109: 248-250.
25. Burman WJ, Stone BL, Reves RR, Wilson ML, Yang Z, El-Hajj H et al. The incidence of false-positive cultures for Mycobacterium tuberculosis. Am J Respir Crit Care Med 1997; 155: 321-326.
26. Chedore P, Th'ng C, Nolan DH, Churchwell GM, Sieffert DE, Hale YM et al. Method for inactivating and fixing unstained smear preparations of mycobacterium tuberculosis for improved laboratory safety. J Clin Microbiol 2002; 40: 4077-4080.
27. Ichiyama S. Advances of laboratory testing for the rapid diagnosis of tuberculosis. Rinsho Byori 2002; 50: 455-462.
28. Collins CH. Laboratory-acquired tuberculosis. Tubercle 1b] 1982; 63: 151-155.
29. Nyirenda TE, Mundy CJ, Harries AD, Banerjee A, Salaniponi FM. Safety in laboratories carrying out sputum smear microscopy: a dilemma for resource-poor countries. Int J Tuberc Lung Dis 1998; 2: 690-693.
30. Cimons M. NIH opens top level biosafety facility. Nat Med 1998; 4: 136.
31. Richmond JY, Knudsen RC, Good RC. Biosafety in the clinical mycobacteriology laboratory. Clin Lab Med 1996; 16: 527-550.
32. van Soolingen D, de Haas PE, Haagsma J, Eger T, Hermans PW, Ritacco V et al. Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis. J Clin Microbiol 1994; 32: 2425-2433.
33. Jarallah JS, Elias AK, Al Hajjaj MS, Bukhari MS, Al Shareef AH, Al-Shammari SA. High rate of rifampicin resistance of Mycobacterium tuberculosis in the Taif region of Saudi Arabia. Tuber Lung Dis 1992; 73: 113-115.
34. Ellis ME, Al-Hajjar S, Bokhari H, Hussein Qadri SM. High proportion of multi-drug resistant Mycobacterium tuberculosis in Saudi Arabia. Scand J Infect Dis 1996; 28: 591-595.
35. Al-Orainey IO, Saeed ES, El-Kassimi FA, Al-Shareef N. Resistance to antituberculosis drugs in Riyadh, Saudi Arabia. Tubercle 1989; 70: 207-210.
36. Schiott CR, Engbaek HC, Vergmann B, Al Motez M, Kassim I. Resistant strains of Mycobacterium tuberculosis in the Gizan Area, Saudi Arabia. Ugeskr Laeger 1984; 146: 4024-4026.
37. Al-Rubaish AM, Madania AA, Al-Muhanna FA. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia. Saudi Med J 2001; 22: 776-779.